Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pure Green CBD/THC tablets for OA knee pain
NCT04195269Phase 2Unknown
- Sponsor
- Pure Green Pharmaceuticals
- Start
- Apr 2020
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of nabiximols in knee osteoarthritis (OA), sponsored by Pure Green Pharmaceuticals. Primary endpoint: Impact on pain due to osteoarthritis of the knee at 30 days. Status: unknown.
02
Drugs
nabiximols
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04195269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04195269.